- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Zogenix Inc+ Add to Watchlist
ZGNX:US4.0400 USD 0.2000 5.21%
As of 20:10:00 ET on 03/07/2014.
Company Profile for Zogenix Inc (ZGNX)
Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.
Key Executives for Zogenix Inc (ZGNX)
|Roger L HawleyCEO/Co-Founder||Stephen J FarrPresident/Co-Founder|
|Cynthia Y RobinsonChief Development Officer||Ann D RhoadsExec VP/CFO/Treasurer/Secy|
|Bradley Stuart Galer "Brad Gale"Exec VP/Chief Medical Officer||Richard Scott ShivelyExec VP/Chief Commercial Ofcr|
|John J TuraninVP/General Mgr:Zogenix Tech||Bret E MegargelVP:Corporate Dev/Co-Founder|
|Stephen H JennerVP:Marketing||Edward F Smith IIIVP:Regulatory Affairs & Drug|
|Mark R ThompsonVP:Sales & Managed Markets||Jeff D DurflingerVP:Technical Ops & Product Supply|